Pharma Marketers Reach Diagnosed Health Audiences Across the Web With ConditionMatch(TM) From Precision Health Media
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 10/17/12 -- today announced positive results and early success for ConditionMatch™, its proprietary page-level targeting technology that aligns healthcare and pharmaceutical marketers with the most relevant, highest performing content across the Web. Targeting niche health condition environments across over 200 health sites and reaching over 57 million unique users per month, ConditionMatch enables page-level content ranking and audience targeting while avoiding privacy concerns and ensuring more effective ad placement as well as brand safety. Precision Health was just ranked in comScore (10/8) as the number-one source for digital health audiences.
According to comScore reports, Precision Health Media advertisers are up to 50 percent more likely to reach a consumer who has filled a prescription when compared to targeting general health portals, such as WebMD. On average, ConditionMatch delivers a click-through rate 40 percent higher than the industry average, and tests by a major pharmaceutical marketer showed that ConditionMatch lowered cost-per-visit by 71 percent.
"Because pharmaceutical marketers have more limitations than other industries targeting consumers online, Precision Health aimed its technology at the content across top health sites to identify the most relevant audiences. It is essential that pharma brands extend their reach beyond health portals as so many patients use search now to find information versus one health site. In fact according to comScore over half Precision Health's visitors do not visit the top four health portals, so we capture a valuable incremental audience," said Bill Jennings, CEO of Precision Health Media. "We are thrilled with the success our customers have seen to date leveraging the performance-driven, page-level targeting within ConditionMatch to reach and engage niche audiences across the Web."
ConditionMatch's page-level content analysis is combined with third-party data, such as Google search trends and historical condition ad performance data, enabling advertisers to precisely target patients with one or more existing medical conditions. It places ad creative around the most deeply relevant content then continuously optimizes each brand's ad campaign for optimal performance.
Attendees of in Philadelphia are encouraged to attend a demo of ConditionMatch on Wednesday, October 17 at 12:20 p.m. ET. To learn more about ConditionMatch, visit: .
New York-based Precision Health Media (formerly Good Health Media) delivers specific health condition audiences to pharma and consumer brands. The company is backed by Metamorphic Ventures, Cava Capital and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch is a trademark of Precision Health Media. For more information, visit .
Carla Rudder
blast! PR for Precision Health Media
225-238-1091
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.10.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 193322
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma Marketers Reach Diagnosed Health Audiences Across the Web With ConditionMatch(TM) From Precision Health Media"
steht unter der journalistisch-redaktionellen Verantwortung von
Precision Health Media (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
